Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . December 5th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Diagnostics - Platelet counts and ultrasonography predict liver fibrosis in hepatitis C chronic hepatitis
Genetics & Genomics - Real-time Taqman method is suitable for hepatitis C virus genotyping
Hepatitis B Virus - Stable inhibition of hepatitis B virus proteins is achieved by viral vector RNA
Hepatitis C Virus - Diagnosis with HCV is more stressful than divorce, job loss, and relocation
Hepatitis Therapy - Zinc supplementation may provide complementary therapy of chronic hepatitis C
Adverse Drug Reaction - Antituberculosis drug-induced hepatotoxicity requires vigilant monitoring
Business & Finance - Liver assist device maker completes first closing of $8M private financing
Diagnostics - Researchers provide details of new studies and findings in the area of diagnostics
Drug Development - BLX-883 found to be safe in phase I study
Finance - Biopharma company reports third-quarter revenues of $1.7 million and a net loss of $2.8 million
Genetics & Genomics - Novel method of genotyping of hepatitis C virus by Taqman real-time PCR chronicled
Virology - New data illuminates research in virology
Hematology - New findings in hematology described
Hepatitis B Epidemiology - Hepatitis B and D viruses are prevalent in the western Brazilian Amazon
Hepatitis B Therapy - Interferon/long-term lamivudine combination therapy is effective in hepatitis B
Hepatitis B Therapy - Recent findings in hepatitis B therapy described
Hepatitis B Virus - Entecavir is well tolerated in lamivudine-refractory hepatitis B patients
Hepatitis B Virus - Erk-mediated GSK-3 beta inactivation upregulates beta-catenin
Virology - Recent studies add new data to virology research
Hepatitis B Virus - HBV vaccine effective in some chronic HBV-infected liver graft recipients
Hepatitis B Virus - Hepatitis B e antigen-negative infection is prevalent in West Bengal, India
Hepatitis B Virus - Hepatitis B virus core and core-related antigen quantified
Hepatitis B Virus - Novel autoregulatory function of hepatitis B virus M protein on surface gene expression reported
Hepatitis C Prognostics - Percentage of hepatitis C virus-infected hepatocytes is good response predictor
Hepatitis C Testing - Phase I trials of Locteron for hepatitis C initiated
Hepatitis C Therapy - Phlebotomy is effective therapy for patients with chronic hepatitis C infections
Hepatitis C Virus - ARCHITECT Anti-HCV assay shows improved specificity for blood donor specimens
Hepatitis C Virus - Antithymocyte globulin induction therapy does not affect graft survival
Hepatitis C Virus - Blood-transmitted viral infections remain high among hemophiliacs in Tunisia
Hepatitis C Virus - Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Hepatitis C Virus - FAS promoter polymorphisms correlate with activity grade in hepatitis C patients
Hepatitis C Virus - Hepatitis C virus core triggers apoptosis in liver cells
Hepatitis C Virus - Host immune responses are vital in hepatitis C virus clearance
Hepatitis C Virus - Inadequate anti-HIV CD8 T-cell responses may be a disease factor in HIV/HCV infected hemophiliacs
Hepatitis C Virus - Parenteral iron replacement might contribute to hepatocellular injury
Hepatitis C Virus - p53, p21ras and mdm2 alterations are late events in hepatocarcinogenesis
Hepatitis E Virus - Novel human hepatitis E virus (HEV) may be seroprevalent in Korea
Hepatitis Therapy - Sargassum polycystum extract protects against acetaminophen-induced changes
Hepatocellular Carcinoma - Research in hepatocellular carcinoma provides new insights
Hepatocellular Carcinoma - Tumor necrosis factor and HCV have key roles in hepatocellular carcinoma
Infectious Diseases - Leptin enhances TNF-alpha production in LPS-stimulated Kupffer cells
Infectious Diseases - Sperm wash and ICSI could be useful for reducing HIV and/or HCV transmission
Liver Transplantation - Fibrosis after liver transplantation involves hepatic stellate cell activation
Nosocomial Infections - Healthcare workers are not at risk for hepatitis C virus infection
Pharmaceutical Research - Viral hepatitis treatment prevents glutathione-mediated acute liver injury
Prognostics - Insulin resistance is the main predictor of nonalcoholic steatohepatitis
Stem Cell Research - Side population cells derived from adult liver generate hepatocyte-like cells
Transplant Medicine - Acyclovir therapy does not prevent recurrent post-transplantation hepatitis
Transplant Medicine - Early hepatic stellate cell activation predicts hepatitis C recurrence
Transplant Medicine - New findings in transplant medicine described
Virology - Data advance knowledge in virology research
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
